Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-12-01
Original SEC Filing: Click here

---

Webplus: SVA/20171201/6-K/2_EX-99.1/000.htm SEC Original: tv480613_ex99-1.htm
Sinovac Biotech Cures Nasdaq Filing Deficiency BEIJING, December 1, 2017 /PRNewswire/ — Sinovac Biotech Ltd. (Nasdaq: SVA)(the “Company” or “Sinovac”), a leading provider of biopharmaceutical products in China, announced today that it has received a Nasdaq Staff letter indicating that the Form 20-F filing delinquency, which was the subject of a prior Nasdaq Staff Determination letter, has been cured after

---

---

Webplus: SVA/20171201/6-K/1/000.htm SEC Original: tv480613_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-12-01CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD, HAIDIAN DISTRICT
BEIJING 100085